The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 08, 2026 for Aayush Agrawal, trustee ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma promoter Aayush Agrawal (through Aayush Agrawal Trust) has created a pledge on 28,55,925 shares of the company, which works out to about 2.29% of Ajanta Pharma's total share capital. The pledge was created on 2 June 2026 and the stated reason is to raise a new loan. After this pledge, the trust's holding stands at around 33.48 lakh shares, of which nearly 28.86 lakh (about 86%) are now encumbered, up from just 30,000 shares pledged earlier. The disclosure was filed with BSE and NSE under Regulation 31(1) and 31(2) of SEBI's Substantial Acquisition of Shares and Takeovers (SAST) Regulations, 2011.
More than 85% of this specific promoter's stake is now pledged, which is a red flag for retail investors as high pledging can indicate leveraged financial positions or stress. The shares themselves have not been sold, so there is no equity dilution, but any future loan default could trigger invocation of the pledged shares and pressure on the stock.